Add to ORKGMethyl aminolevulinate-hydrochloride cream (Metvix ® [in Canada] and Metvixia ® [in the US], Galderma) in combination with photodynamic therapy (PDT) provides an effective treatment option for actinic keratoses (AKs), superficial basal cell carcinoma (sBCC), and Bowen’s disease (BD). Good clinical outcomes have been reported in the literature. Complete responses (CRs) in A
?Background Photodynamic therapy (PDT) is an accepted treatment for superficial basal cel carcinoma ...
Topical 5-aminolaevulinic acid (ALA) photodynamic therapy (PDT) is increasingly used for superficial...
Background Photodynamic therapy (PDT) with 5-aminolaevulinic acid (ALA) or its methylester [methyl-...
Non‐melanoma skin cancer (NMSC) is traditionally treated with surgical excision. Nonsurgical methods...
Photodynamic therapy (PDT) with topical methyl aminolevulinate ( MAL) administered in two treatment ...
Photodynamic therapy with methyl aminolevulinate (MAL-PDT) is a non-invasive therapy for superficial...
Non-melanoma skin cancer (NMSC) is the most common malignancy among the Caucasian population. Photod...
INTRODUCTION: Since actinic keratoses (AKs) often appear in areas with field cancerization, photodyn...
Photodynamic therapy involves the use of light to activate a photosensitizer, localized in the disea...
Photodynamic therapy with methyl aminolevulinate (MAL-PDT) is a non-invasive therapy for superficial...
Photodynamic therapy (PDT) with methyl aminolevulinate (MAL) is approved in Europe for the treatment...
Conventional treatment of basal cell carcinoma (BCC) causes morbidity and/or disfigurement in some p...
Background: Basal cell carcinoma (BCC) may be difficult to treat by conventional means, particularly...
Daylight photodynamic therapy (DL-PDT) with methyl aminolevulinate (MAL) is a simplified PDT procedu...
The authors report the use of photodynamic therapy with methyl aminolevulinate (Metvix (R)) in a pat...
?Background Photodynamic therapy (PDT) is an accepted treatment for superficial basal cel carcinoma ...
Topical 5-aminolaevulinic acid (ALA) photodynamic therapy (PDT) is increasingly used for superficial...
Background Photodynamic therapy (PDT) with 5-aminolaevulinic acid (ALA) or its methylester [methyl-...
Non‐melanoma skin cancer (NMSC) is traditionally treated with surgical excision. Nonsurgical methods...
Photodynamic therapy (PDT) with topical methyl aminolevulinate ( MAL) administered in two treatment ...
Photodynamic therapy with methyl aminolevulinate (MAL-PDT) is a non-invasive therapy for superficial...
Non-melanoma skin cancer (NMSC) is the most common malignancy among the Caucasian population. Photod...
INTRODUCTION: Since actinic keratoses (AKs) often appear in areas with field cancerization, photodyn...
Photodynamic therapy involves the use of light to activate a photosensitizer, localized in the disea...
Photodynamic therapy with methyl aminolevulinate (MAL-PDT) is a non-invasive therapy for superficial...
Photodynamic therapy (PDT) with methyl aminolevulinate (MAL) is approved in Europe for the treatment...
Conventional treatment of basal cell carcinoma (BCC) causes morbidity and/or disfigurement in some p...
Background: Basal cell carcinoma (BCC) may be difficult to treat by conventional means, particularly...
Daylight photodynamic therapy (DL-PDT) with methyl aminolevulinate (MAL) is a simplified PDT procedu...
The authors report the use of photodynamic therapy with methyl aminolevulinate (Metvix (R)) in a pat...
?Background Photodynamic therapy (PDT) is an accepted treatment for superficial basal cel carcinoma ...
Topical 5-aminolaevulinic acid (ALA) photodynamic therapy (PDT) is increasingly used for superficial...
Background Photodynamic therapy (PDT) with 5-aminolaevulinic acid (ALA) or its methylester [methyl-...